ğŸ“Š HEALTH TOPIC OF THE WEEK: MULTI-CANCER EARLY DETECTION

We have standard screening for 5 cancers:
â†’ Breast (mammogram)
â†’ Colon (colonoscopy)
â†’ Cervical (Pap smear)
â†’ Lung (CT for high-risk)
â†’ Prostate (PSA, controversial)

That leaves ~70% of cancer deaths from cancers we've never had a way to screen for.

Pancreatic. Ovarian. Liver. Stomach. Esophageal.

By the time these cause symptoms, they're often stage IV.

Enter MCED: Multi-Cancer Early Detection

A single blood draw that can detect signals from 50+ cancer types.

How it works:

ğŸ©¸ Blood draw â†’ ğŸ§¬ cfDNA extraction â†’ ğŸ” Methylation analysis â†’ ğŸ“ Cancer Signal Origin

Tumors shed cell-free DNA (cfDNA) into the bloodstream. This DNA carries cancer-specific methylation patterns that can identify:

1. IF a cancer signal is present
2. WHERE in the body to look

The numbers:

âœ“ 50+ cancer types detected
âœ“ 83% detection rate for Stage I-III cancers
âœ“ 0.5% false positive rate
âœ“ 88% accuracy for tissue of origin

The key value:

For pancreatic cancer, median survival at diagnosis is ~6 months.

MCED can detect it when it's still localizedâ€”when survival is 5+ years.

This isn't replacing your colonoscopy or mammogram. It's adding coverage for the cancers we've never been able to find early.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#HealthTopic #CancerScreening #MCED #EarlyDetection #PrecisionMedicine #Bioscope
